{"id":"https://openalex.org/W2897355212","doi":null,"title":"Combination of the aptamer AS1411 with paclitaxel or Ara-C produces synergistic inhibition of cancer cell growth","display_name":"Combination of the aptamer AS1411 with paclitaxel or Ara-C produces synergistic inhibition of cancer cell growth","publication_year":2007,"publication_date":"2007-05-01","ids":{"openalex":"https://openalex.org/W2897355212","mag":"2897355212"},"language":"en","primary_location":{"id":"mag:2897355212","doi":null,"is_oa":false,"landing_page_url":"http://cancerres.aacrjournals.org/content/67/9_Supplement/4818","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022309270","display_name":"Christy Ritchie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christy Ritchie","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Benjamin A. Doran","orcid":"https://orcid.org/0000-0003-4713-5562","observed_orcids":["https://orcid.org/0000-0003-4713-5562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin A. Doran","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-4713-5562","affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006654729","display_name":"Kirti Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirti Shah","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059069081","display_name":"Hakim Djeha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hakim Djeha","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080549837","display_name":"Donna Dobinson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donna Dobinson","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077827956","display_name":"Gail Rowlinson\u2010Busza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gail Rowlinson\u2010Busza","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023669521","display_name":"Nigel S. Courtenay-Luck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nigel Courtenay-Luck","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054718633","display_name":"Colin J. Green","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Green","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-3459-6298","affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"D. I. Jones","orcid":"https://orcid.org/0000-0002-0117-7567","observed_orcids":["https://orcid.org/0000-0002-0117-7567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. I. Jones","raw_affiliation_strings":["Antisoma, Ealing, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0117-7567","affiliations":[{"raw_affiliation_string":"Antisoma, Ealing, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1088,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.45827427,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"67","issue":null,"first_page":"4818","last_page":"4818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.05860000103712082,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.03310000151395798,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/as1411","display_name":"AS1411","score":0.9929999709129333},{"id":"https://openalex.org/keywords/nucleic-acid-aptamers","display_name":"nucleic acid aptamers","score":0.8220000267028809},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9100000262260437},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8610000014305115},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/tumor-cell-growth-inhibition","display_name":"tumor cell growth inhibition","score":0.7929999828338623},{"id":"https://openalex.org/keywords/nucleolin","display_name":"nucleolin","score":0.6150000095367432},{"id":"https://openalex.org/keywords/combination-index","display_name":"combination index","score":0.6579999923706055},{"id":"https://openalex.org/keywords/kidney-cancer","display_name":"kidney cancer","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6555608510971069},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5481708645820618},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5332158803939819},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5277243852615356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5065900087356567},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.49919867515563965},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4927211105823517},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4844829738140106},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.45257633924484253},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4489228427410126},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3993355333805084},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3788984417915344},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37733450531959534},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29116976261138916},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2693721652030945},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23914438486099243},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22872114181518555},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22779664397239685}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2897355212","doi":null,"is_oa":false,"landing_page_url":"http://cancerres.aacrjournals.org/content/67/9_Supplement/4818","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2118908256","https://openalex.org/W2900043549","https://openalex.org/W2319951868","https://openalex.org/W7204109360","https://openalex.org/W2106819793","https://openalex.org/W4386942017","https://openalex.org/W2986752244","https://openalex.org/W2504553056","https://openalex.org/W1985290031","https://openalex.org/W3186554202"],"abstract_inverted_index":{"4818":[0],"AS1411":[2,17,127,140,228,251],"is":[3,18,40],"the":[4,93,123,211,246,260,269,275],"first":[5],"nucleic":[6],"acid":[7],"aptamer":[8],"to":[9,36,42,48,105,121,143,169,274],"be":[10,254],"tested":[11,103],"as":[12,28],"a":[13,19,29,32,63,148,187],"treatment":[14],"for":[15,204],"cancer.":[16],"26-base":[20],"unmodified":[21],"phosphodiester-based":[22],"guanosine":[23],"rich":[24],"oligonucleotide":[25],"(GRO),":[26],"which,":[27],"dimer,":[30],"forms":[31],"quartet":[33],"structure":[34],"resistant":[35],"serum":[37],"nucleases.":[38],"It":[39],"postulated":[41],"exert":[43],"anti-cancer":[44],"activity":[45,72],"by":[46],"binding":[47],"cell":[49,57,137,145,154,172,180],"surface":[50],"nucleolin;":[51],"this":[52],"then":[53],"results":[54],"in":[55,75,134,268,281],"S-phase":[56],"cycle":[58],"arrest":[59],"and":[60,92,160,252,288],"apoptosis.":[61],"In":[62],"Phase":[64],"I":[65],"dose-escalation":[66],"trial":[67],"promising":[68],"signs":[69],"of":[70,80,108,111,117,125,147,151,166,190,192,210,248,250,263,277],"anticancer":[71],"were":[73,184],"reported":[74],"renal":[76],"cancer":[77,136,153,182],"patients":[78,82],"(9":[79],"12":[81],"showed":[83],"clinical":[84],"benefit":[85],"(stable":[86],"disease,":[87],"partial":[88],"or":[89,218,238],"complete":[90],"response))":[91],"drug":[94],"produced":[95],"no":[96],"serious":[97],"adverse":[98],"events":[99],"at":[100],"any":[101],"dose":[102],"(up":[104],"2":[106],"cycles":[107],"7-day":[109],"infusions":[110],"40":[112],"mg/kg/day).":[113],"The":[115],"aim":[116],"these":[118],"studies":[119,280],"was":[120,141],"evaluate":[122],"potential":[124],"combining":[126],"with":[128,186,207,235,271,283,286],"various":[129],"traditional":[130],"cytotoxic":[131,212],"chemotherapeutics,":[132],"using":[133],"vitro":[135],"lines.":[138],"Initially":[139],"shown":[142],"induce":[144],"killing":[146],"broad":[149],"range":[150],"human":[152,178],"lines,":[155],"derived":[156],"from":[157],"both":[158],"hematologic":[159],"solid":[161],"cancers,":[162],"typically":[163],"requiring":[164],"concentrations":[165,209],"around":[167],"5\u03bcM":[168],"cause":[170,198],"50%":[171],"kill.":[173],"For":[174],"combination":[175,225,279],"studies,":[176],"A549":[177],"non-small":[179],"lung":[181],"cells":[183],"incubated":[185],"fixed":[188],"concentration":[189,194],"3\u03bcM":[191],"AS1411(a":[193],"that":[195],"did":[196],"not":[197],"growth":[199,231],"inhibition":[200,232],"when":[201,233],"used":[202,234],"alone)":[203],"6":[205],"days":[206],"varying":[208],"agents":[213],"(cisplatin,":[214],"paclitaxel,":[215],"gemcitabine,":[216],"Ara-C":[217],"5-fluorouracil)":[219],"added":[220],"on":[221],"day":[222],"3.":[223],"Using":[224],"index":[226],"analysis,":[227],"demonstrated":[229],"synergistic":[230],"either":[236],"paclitaxel":[237,287],"Ara-C.":[239,289],"Further":[240],"work":[241],"has":[242],"given":[243],"insights":[244],"into":[245],"mechanism":[247],"action":[249],"will":[253],"presented.":[255],"These":[257],"data,":[258],"alongside":[259],"general":[261],"lack":[262],"toxicities":[264],"observed":[265],"thus":[266],"far":[267],"clinic":[270],"AS1411,":[272,284],"attest":[273],"promise":[276],"conducting":[278],"man":[282],"especially":[285]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2018-10-26T00:00:00"}